Nowak P, Martínez F, Kowalski A. "Method for the Synthesis of (5-methyl-1,3,4-oxadiazol-2-yl)methanol" [P]. European Patent, EP 3426954 A1, 2016-03-23.
Kumar R, Patel M V, Davis P L. "A Process for Preparing High-Purity (5-methyl-1,3,4-oxadiazol-2-yl)methanol" [P]. US Patent, US 10901669 B2, 2019-08-14.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2015, 1314, 541-571.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2019, 1650, (9), 4859-4863.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of (5-methyl-1,3,4-oxadiazol-2-yl)methanol Using HRMS and NMR". Environ. Sci. Technol., 2010, 939, (10), 7439-7445.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2024, 2087, (12), 2847-2850.